Click here to get full coverage on Pontifax funds sell Keros Therapeutics (KROS) shares for $84.97m - Investing.com

Pontifax funds sell Keros Therapeutics (KROS) shares for $84.97m  Investing.com

Pontifax funds sell Keros Therapeutics (KROS) shares for $84.97m - Investing.com

Click here to get full coverage on How to read the order book for KROS - 2025 Market Outlook & Momentum Based Trading Signals - newser.com

How to read the order book for KROS - 2025 Market Outlook & Momentum Based Trading Signals  newser.com

How to read the order book for KROS - 2025 Market Outlook & Momentum Based Trading Signals - newser.com

Click here to get full coverage on Insider Sale: 10% owner at $KROS Sells 4,391,237 Shares - Quiver Quantitative

Insider Sale: 10% owner at $KROS Sells 4,391,237 Shares  Quiver Quantitative

Insider Sale: 10% owner at $KROS Sells 4,391,237 Shares - Quiver Quantitative

Click here to get full coverage on $375M Capital Return: Keros Therapeutics repurchases $181M, plans $194M tender offer by Oct 2025 - Stock Titan

$375M Capital Return: Keros Therapeutics repurchases $181M, plans $194M tender offer by Oct 2025  Stock Titan

$375M Capital Return: Keros Therapeutics repurchases $181M, plans $194M tender offer by Oct 2025 - Stock Titan

Click here to get full coverage on Keros Therapeutics (NASDAQ:KROS) Sees Unusually-High Trading Volume - Time to Buy? - MarketBeat

Keros Therapeutics (NASDAQ:KROS) Sees Unusually-High Trading Volume - Time to Buy?  MarketBeat

Keros Therapeutics (NASDAQ:KROS) Sees Unusually-High Trading Volume - Time to Buy? - MarketBeat

Click here to get full coverage on Keros up after acquiring major investors' shares at premium; unveils $194 million buyback plan - TradingView

Keros up after acquiring major investors' shares at premium; unveils $194 million buyback plan  TradingView

Keros up after acquiring major investors' shares at premium; unveils $194 million buyback plan - TradingView

Click here to get full coverage on Using fundamentals and technicals on KROS - Portfolio Risk Summary & Accurate Trade Setup Notifications - newser.com

Using fundamentals and technicals on KROS - Portfolio Risk Summary & Accurate Trade Setup Notifications  newser.com

Using fundamentals and technicals on KROS - Portfolio Risk Summary & Accurate Trade Setup Notifications - newser.com

Click here to get full coverage on Keros Therapeutics (KROS) Announces Share Repurchase Agreements - GuruFocus

Keros Therapeutics (KROS) Announces Share Repurchase Agreements  GuruFocus

Keros Therapeutics (KROS) Announces Share Repurchase Agreements - GuruFocus

Click here to get full coverage on Keros Therapeutics, Inc. (NASDAQ:KROS) Looks Inexpensive But Perhaps Not Attractive Enough - 富途牛牛

Keros Therapeutics, Inc. (NASDAQ:KROS) Looks Inexpensive But Perhaps Not Attractive Enough  富途牛牛

Keros Therapeutics, Inc. (NASDAQ:KROS) Looks Inexpensive But Perhaps Not Attractive Enough - 富途牛牛

Click here to get full coverage on Investors in Keros Therapeutics (NASDAQ:KROS) have unfortunately lost 72% over the last year - Yahoo Finance

Investors in Keros Therapeutics (NASDAQ:KROS) have unfortunately lost 72% over the last year  Yahoo Finance

Investors in Keros Therapeutics (NASDAQ:KROS) have unfortunately lost 72% over the last year - Yahoo Finance

Click here to get full coverage on Adar1 partners sells Keros Therapeutics (KROS) shares worth $95.6m - Investing.com

Adar1 partners sells Keros Therapeutics (KROS) shares worth $95.6m  Investing.com

Adar1 partners sells Keros Therapeutics (KROS) shares worth $95.6m - Investing.com

Click here to get full coverage on Men’s Tennis Adds Jason Kros as Assistant Coach - Ole Miss Athletics

Men’s Tennis Adds Jason Kros as Assistant Coach  Ole Miss Athletics

Men’s Tennis Adds Jason Kros as Assistant Coach - Ole Miss Athletics

Click here to get full coverage on Come experience Huskers Live On Tap at Kros Strain Brewing on Oct. 15 - 247Sports

Come experience Huskers Live On Tap at Kros Strain Brewing on Oct. 15  247Sports

Come experience Huskers Live On Tap at Kros Strain Brewing on Oct. 15 - 247Sports

Click here to get full coverage on 'A beer for everybody': Beer brewed in La Vista named official craft beer of the Huskers - KETV

'A beer for everybody': Beer brewed in La Vista named official craft beer of the Huskers  KETV

'A beer for everybody': Beer brewed in La Vista named official craft beer of the Huskers - KETV

Click here to get full coverage on Keros Therapeutics (NASDAQ:KROS) Major Shareholder Adar1 Capital Management, Llc Sells 5,389,264 Shares - MarketBeat

Keros Therapeutics (NASDAQ:KROS) Major Shareholder Adar1 Capital Management, Llc Sells 5,389,264 Shares  MarketBeat

Keros Therapeutics (NASDAQ:KROS) Major Shareholder Adar1 Capital Management, Llc Sells 5,389,264 Shares - MarketBeat

Click here to get full coverage on Quantitative breakdown of KROS recent move - M&A Rumor & AI Driven Price Forecasts - newser.com

Quantitative breakdown of KROS recent move - M&A Rumor & AI Driven Price Forecasts  newser.com

Quantitative breakdown of KROS recent move - M&A Rumor & AI Driven Price Forecasts - newser.com

Click here to get full coverage on Jason Kros - Men's Tennis Coach - Ole Miss Athletics - Hotty Toddy - Ole Miss Athletics

Jason Kros - Men's Tennis Coach - Ole Miss Athletics - Hotty Toddy  Ole Miss Athletics

Jason Kros - Men's Tennis Coach - Ole Miss Athletics - Hotty Toddy - Ole Miss Athletics

Click here to get full coverage on Keros Therapeutics, Inc. (NASDAQ:KROS) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

Keros Therapeutics, Inc. (NASDAQ:KROS) Receives Consensus Rating of "Hold" from Brokerages  MarketBeat

Keros Therapeutics, Inc. (NASDAQ:KROS) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

Click here to get full coverage on Keros Therapeutics: A Potential Dart Throw (NASDAQ:KROS) - Seeking Alpha

Keros Therapeutics: A Potential Dart Throw (NASDAQ:KROS)  Seeking Alpha

Keros Therapeutics: A Potential Dart Throw (NASDAQ:KROS) - Seeking Alpha

Click here to get full coverage on KROS vs. EXAS: Which Stock Should Value Investors Buy Now? - Yahoo Finance

KROS vs. EXAS: Which Stock Should Value Investors Buy Now?  Yahoo Finance

KROS vs. EXAS: Which Stock Should Value Investors Buy Now? - Yahoo Finance

Click here to get full coverage on Weiss Ratings Reaffirms "Sell (D)" Rating for Keros Therapeutics (NASDAQ:KROS) - MarketBeat

Weiss Ratings Reaffirms "Sell (D)" Rating for Keros Therapeutics (NASDAQ:KROS)  MarketBeat

Weiss Ratings Reaffirms "Sell (D)" Rating for Keros Therapeutics (NASDAQ:KROS) - MarketBeat

Click here to get full coverage on Largest Shareholder (13.3%) Confronts Keros Board Over Delayed $375M Capital Return and Strategic Direction - Stock Titan

Largest Shareholder (13.3%) Confronts Keros Board Over Delayed $375M Capital Return and Strategic Direction  Stock Titan

Largest Shareholder (13.3%) Confronts Keros Board Over Delayed $375M Capital Return and Strategic Direction - Stock Titan

Click here to get full coverage on Husker fans can cheer with beer: ‘Cornhusker Crusher’ debuts alongside custom Bud Light can - KOLN | Nebraska Local News, Weather, Sports | Lincoln, NE

Husker fans can cheer with beer: ‘Cornhusker Crusher’ debuts alongside custom Bud Light can  KOLN | Nebraska Local News, Weather, Sports | Lincoln, NE

Husker fans can cheer with beer: ‘Cornhusker Crusher’ debuts alongside custom Bud Light can - KOLN | Nebraska Local News, Weather, Sports | Lincoln, NE

Click here to get full coverage on Karrion Kross Reveals Weird Backstage Interaction After Famous WrestleMania Promo - SEScoops

Karrion Kross Reveals Weird Backstage Interaction After Famous WrestleMania Promo  SEScoops

Karrion Kross Reveals Weird Backstage Interaction After Famous WrestleMania Promo - SEScoops

Click here to get full coverage on Keros Therapeutics, Inc. (KROS) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance

Keros Therapeutics, Inc. (KROS) Reports Q2 Loss, Beats Revenue Estimates  Yahoo Finance

Keros Therapeutics, Inc. (KROS) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance

Click here to get full coverage on Assenagon Asset Management S.A. Purchases 36,360 Shares of Keros Therapeutics, Inc. $KROS - MarketBeat

Assenagon Asset Management S.A. Purchases 36,360 Shares of Keros Therapeutics, Inc. $KROS  MarketBeat

Assenagon Asset Management S.A. Purchases 36,360 Shares of Keros Therapeutics, Inc. $KROS - MarketBeat

Click here to get full coverage on Indian Reality TV Gets Korean Makeover as Kross Pictures Unveils Four-Format Slate at Busan Market (EXCLUSIVE) - Variety

Indian Reality TV Gets Korean Makeover as Kross Pictures Unveils Four-Format Slate at Busan Market (EXCLUSIVE)  Variety

Indian Reality TV Gets Korean Makeover as Kross Pictures Unveils Four-Format Slate at Busan Market (EXCLUSIVE) - Variety

Click here to get full coverage on Keros Therapeutics, Inc. (KROS) Stock Analysis: Exploring a Strong Revenue Growth and Potential 47.63% Upside - DirectorsTalk Interviews

Keros Therapeutics, Inc. (KROS) Stock Analysis: Exploring a Strong Revenue Growth and Potential 47.63% Upside  DirectorsTalk Interviews

Keros Therapeutics, Inc. (KROS) Stock Analysis: Exploring a Strong Revenue Growth and Potential 47.63% Upside - DirectorsTalk Interviews

Click here to get full coverage on Clinical-Stage Biotech Keros Therapeutics Featured at Wells Fargo and H.C. Wainwright Healthcare Events - Stock Titan

Clinical-Stage Biotech Keros Therapeutics Featured at Wells Fargo and H.C. Wainwright Healthcare Events  Stock Titan

Clinical-Stage Biotech Keros Therapeutics Featured at Wells Fargo and H.C. Wainwright Healthcare Events - Stock Titan

Click here to get full coverage on KROS's Gary Determan still has love for Radio in 50th Season - Clinton Herald

KROS's Gary Determan still has love for Radio in 50th Season  Clinton Herald

KROS's Gary Determan still has love for Radio in 50th Season - Clinton Herald

Click here to get full coverage on Kross & Scarlett: Signing with AEW right now ‘wouldn’t be fair to Tony’ - Cageside Seats

Kross & Scarlett: Signing with AEW right now ‘wouldn’t be fair to Tony’  Cageside Seats

Kross & Scarlett: Signing with AEW right now ‘wouldn’t be fair to Tony’ - Cageside Seats

Click here to get full coverage on Build-Outs Of Coffee: Kross Coffee Roasters In Chania, Greece - Sprudge

Build-Outs Of Coffee: Kross Coffee Roasters In Chania, Greece  Sprudge

Build-Outs Of Coffee: Kross Coffee Roasters In Chania, Greece - Sprudge

Click here to get full coverage on Killer Kross and Priscilla Kelly return to MLW - Cageside Seats

Killer Kross and Priscilla Kelly return to MLW  Cageside Seats

Killer Kross and Priscilla Kelly return to MLW - Cageside Seats

Click here to get full coverage on Killer Kross Becomes Super Heavyweight Cup Inaugural Winner At DEFY Wrestling’s “AEON” - PWPonderings

Killer Kross Becomes Super Heavyweight Cup Inaugural Winner At DEFY Wrestling’s “AEON”  PWPonderings

Killer Kross Becomes Super Heavyweight Cup Inaugural Winner At DEFY Wrestling’s “AEON” - PWPonderings

Click here to get full coverage on Karrion Kross and Scarlett Moved to WWE Alumni Page, Scarlett Releases Statement - VICE

Karrion Kross and Scarlett Moved to WWE Alumni Page, Scarlett Releases Statement  VICE

Karrion Kross and Scarlett Moved to WWE Alumni Page, Scarlett Releases Statement - VICE

Click here to get full coverage on Keros Transforms Pipeline: Focuses All Resources on Promising DMD Drug KER-065 as Phase 2 Trial Approaches - Stock Titan

Keros Transforms Pipeline: Focuses All Resources on Promising DMD Drug KER-065 as Phase 2 Trial Approaches  Stock Titan

Keros Transforms Pipeline: Focuses All Resources on Promising DMD Drug KER-065 as Phase 2 Trial Approaches - Stock Titan

Click here to get full coverage on Karrion Kross Breaks Silence On WWE Departure - Newsweek

Karrion Kross Breaks Silence On WWE Departure  Newsweek

Karrion Kross Breaks Silence On WWE Departure - Newsweek

Click here to get full coverage on Karrion Kross Sends Strong Message To Fans Questioning Legitimacy Of WWE Exit - Newsweek

Karrion Kross Sends Strong Message To Fans Questioning Legitimacy Of WWE Exit  Newsweek

Karrion Kross Sends Strong Message To Fans Questioning Legitimacy Of WWE Exit - Newsweek

Click here to get full coverage on Update On Karrion Kross' Career Inside And Outside The Ring - Sports Illustrated

Update On Karrion Kross' Career Inside And Outside The Ring  Sports Illustrated

Update On Karrion Kross' Career Inside And Outside The Ring - Sports Illustrated

Click here to get full coverage on Karrion Kross Reveals WWE Gave Him Shocking Contract Ultimatum - Newsweek

Karrion Kross Reveals WWE Gave Him Shocking Contract Ultimatum  Newsweek

Karrion Kross Reveals WWE Gave Him Shocking Contract Ultimatum - Newsweek

Click here to get full coverage on Karrion Kross And Scarlett's First Announced Appearance After WWE Exit Revealed - Sports Illustrated

Karrion Kross And Scarlett's First Announced Appearance After WWE Exit Revealed  Sports Illustrated

Karrion Kross And Scarlett's First Announced Appearance After WWE Exit Revealed - Sports Illustrated

Click here to get full coverage on Karrion Kross And Scarlett's Indy Rates Raise Questions Over WWE Departures - Sports Illustrated

Karrion Kross And Scarlett's Indy Rates Raise Questions Over WWE Departures  Sports Illustrated

Karrion Kross And Scarlett's Indy Rates Raise Questions Over WWE Departures - Sports Illustrated

Click here to get full coverage on Karrion Kross Makes First Post-WWE Move - Newsweek

Karrion Kross Makes First Post-WWE Move  Newsweek

Karrion Kross Makes First Post-WWE Move - Newsweek

Click here to get full coverage on Kross, Chiefs Walk off Cubs in 10 Innings - MLB.com

Kross, Chiefs Walk off Cubs in 10 Innings  MLB.com

Kross, Chiefs Walk off Cubs in 10 Innings - MLB.com

Click here to get full coverage on Karrion Kross Books First Match Since WWE Departure - Newsweek

Karrion Kross Books First Match Since WWE Departure  Newsweek

Karrion Kross Books First Match Since WWE Departure - Newsweek

Click here to get full coverage on New Developments Regarding Karrion Kross As WWE Contract Nears Expiration - Sports Illustrated

New Developments Regarding Karrion Kross As WWE Contract Nears Expiration  Sports Illustrated

New Developments Regarding Karrion Kross As WWE Contract Nears Expiration - Sports Illustrated

Click here to get full coverage on The Righteous And Killer Kross Teased A New Faction At WRESTLEPRO's KILLER SHOW - TheRingReport.com

The Righteous And Killer Kross Teased A New Faction At WRESTLEPRO's KILLER SHOW  TheRingReport.com

The Righteous And Killer Kross Teased A New Faction At WRESTLEPRO's KILLER SHOW - TheRingReport.com

Click here to get full coverage on Karrion Kross Addresses WWE Contract Situation As Expiration Reportedly Nears - Sports Illustrated

Karrion Kross Addresses WWE Contract Situation As Expiration Reportedly Nears  Sports Illustrated

Karrion Kross Addresses WWE Contract Situation As Expiration Reportedly Nears - Sports Illustrated

Click here to get full coverage on Lena Kross Competing At Fight Factory Wrestling’s No Thanks Given - PWPonderings

Lena Kross Competing At Fight Factory Wrestling’s No Thanks Given  PWPonderings

Lena Kross Competing At Fight Factory Wrestling’s No Thanks Given - PWPonderings

Click here to get full coverage on Karrion Kross says WWE pulled contract offer after 24 hours: 'We still want to work it out' - CBS Sports

Karrion Kross says WWE pulled contract offer after 24 hours: 'We still want to work it out'  CBS Sports

Karrion Kross says WWE pulled contract offer after 24 hours: 'We still want to work it out' - CBS Sports

Click here to get full coverage on Kevin Kesar Speaks Out: Why Karrion Kross/WWE Talks Fell Apart - Slam Wrestling

Kevin Kesar Speaks Out: Why Karrion Kross/WWE Talks Fell Apart  Slam Wrestling

Kevin Kesar Speaks Out: Why Karrion Kross/WWE Talks Fell Apart - Slam Wrestling

Click here to get full coverage on Karrion Kross Releases New Theme Song After WWE Exit - Newsweek

Karrion Kross Releases New Theme Song After WWE Exit  Newsweek

Karrion Kross Releases New Theme Song After WWE Exit - Newsweek

Click here to get full coverage on Drew McIntyre Breaks Silence on Karrion Kross’ WWE Departure - Newsweek

Drew McIntyre Breaks Silence on Karrion Kross’ WWE Departure  Newsweek

Drew McIntyre Breaks Silence on Karrion Kross’ WWE Departure - Newsweek

Click here to get full coverage on FDA Grants Special Status to New Duchenne Muscular Dystrophy Drug: Keros' KER-065 Gets Orphan Designation - Stock Titan

FDA Grants Special Status to New Duchenne Muscular Dystrophy Drug: Keros' KER-065 Gets Orphan Designation  Stock Titan

FDA Grants Special Status to New Duchenne Muscular Dystrophy Drug: Keros' KER-065 Gets Orphan Designation - Stock Titan

Click here to get full coverage on KROS Stock Analysis and Forecast - Inflation Impact on Stocks & Free Rapid Return Acceleration - earlytimes.in

KROS Stock Analysis and Forecast - Inflation Impact on Stocks & Free Rapid Return Acceleration  earlytimes.in

KROS Stock Analysis and Forecast - Inflation Impact on Stocks & Free Rapid Return Acceleration - earlytimes.in

Click here to get full coverage on Karrion Kross Discusses WWE Contract Ending on Video, Scarlett Confirms Exit - Bleacher Report

Karrion Kross Discusses WWE Contract Ending on Video, Scarlett Confirms Exit  Bleacher Report

Karrion Kross Discusses WWE Contract Ending on Video, Scarlett Confirms Exit - Bleacher Report

Click here to get full coverage on WATCH: Karrion Kross Makes First Post-WWE Apperance To Attack Former WWE Champ - Yahoo Sports

WATCH: Karrion Kross Makes First Post-WWE Apperance To Attack Former WWE Champ  Yahoo Sports

WATCH: Karrion Kross Makes First Post-WWE Apperance To Attack Former WWE Champ - Yahoo Sports

Click here to get full coverage on Karrion Kross Reveals Why WWE Contract Negotiations Fell Apart - Sports Illustrated

Karrion Kross Reveals Why WWE Contract Negotiations Fell Apart  Sports Illustrated

Karrion Kross Reveals Why WWE Contract Negotiations Fell Apart - Sports Illustrated

Click here to get full coverage on Keros Launches Pivotal Phase 3 Trial for Blood Disorder Drug, Secures $10M from Takeda Partnership - Stock Titan

Keros Launches Pivotal Phase 3 Trial for Blood Disorder Drug, Secures $10M from Takeda Partnership  Stock Titan

Keros Launches Pivotal Phase 3 Trial for Blood Disorder Drug, Secures $10M from Takeda Partnership - Stock Titan

Click here to get full coverage on Karrion Kross opens up on his departure from WWE and what comes next: 'This is baffling to me, too' - Yahoo Sports

Karrion Kross opens up on his departure from WWE and what comes next: 'This is baffling to me, too'  Yahoo Sports

Karrion Kross opens up on his departure from WWE and what comes next: 'This is baffling to me, too' - Yahoo Sports

Click here to get full coverage on Killer Kross Taking On Matt Cardona At HOG With Glory Comes Pride - PWPonderings

Killer Kross Taking On Matt Cardona At HOG With Glory Comes Pride  PWPonderings

Killer Kross Taking On Matt Cardona At HOG With Glory Comes Pride - PWPonderings

Click here to get full coverage on Nick Gage, Killer Kross, and Scarlett Return to Game Changer Wrestling at GCW Homecoming Night 1 - PWPonderings

Nick Gage, Killer Kross, and Scarlett Return to Game Changer Wrestling at GCW Homecoming Night 1  PWPonderings

Nick Gage, Killer Kross, and Scarlett Return to Game Changer Wrestling at GCW Homecoming Night 1 - PWPonderings

Click here to get full coverage on Karrion Kross Addresses WWE Rumors, Latest on El Grande Americano and the Righteous - Bleacher Report

Karrion Kross Addresses WWE Rumors, Latest on El Grande Americano and the Righteous  Bleacher Report

Karrion Kross Addresses WWE Rumors, Latest on El Grande Americano and the Righteous - Bleacher Report

Click here to get full coverage on Karrion Kross and Scarlett Moved to WWE Alumni Page — Real Exit or Storyline Swerve? - DraftKings Network

Karrion Kross and Scarlett Moved to WWE Alumni Page — Real Exit or Storyline Swerve?  DraftKings Network

Karrion Kross and Scarlett Moved to WWE Alumni Page — Real Exit or Storyline Swerve? - DraftKings Network

Click here to get full coverage on Karrion Kross Announces First Post-WWE In-Ring Appearance - Sports Illustrated

Karrion Kross Announces First Post-WWE In-Ring Appearance  Sports Illustrated

Karrion Kross Announces First Post-WWE In-Ring Appearance - Sports Illustrated

Click here to get full coverage on Karrion Kross Was Pulled From A Major WWE Match At The Last Minute - Sports Illustrated

Karrion Kross Was Pulled From A Major WWE Match At The Last Minute  Sports Illustrated

Karrion Kross Was Pulled From A Major WWE Match At The Last Minute - Sports Illustrated

Click here to get full coverage on Kross Combative highlights self defense Krav Maga classes | News - fox23.com

Kross Combative highlights self defense Krav Maga classes | News  fox23.com

KROS

Price Chart

Key Statistics

Technicals

About KROS

Latest News

Pontifax funds sell Keros Therapeutics (KROS) shares for $84.97m - Investing.com

How to read the order book for KROS - 2025 Market Outlook & Momentum Based Trading Signals - newser.com

Insider Sale: 10% owner at $KROS Sells 4,391,237 Shares - Quiver Quantitative

Advanced Charts

Top Gainers

Top Losers